[CONTENT]
eMedinexus

Editorial

Dr k k Aggarwal

CMAAO Corona Facts and Myth Buster: Mortality Reduction

Dr K K Aggarwal, President CMAAO
26th June 2020
Multispeciality
With inputs from Dr Monica Vasudev
956: Round Table Expert Zoom Meeting on “Mortality reduction in Covid-19” 20th June, 2020, 11am-12pm. Participants : Dr KK Aggarwal; Dr Ashok Gupta; Dr Suneela Garg; Dr Alex Thomas; Dr DR Rai; Dr JA Jayalal; Dr Jayakrishnan Alapet; Dr PN Arora; Mrs Upasana Arora; Ms Meenakshi Datta Ghosh; Dr K Kalra; Ms Ira Gupta; Dr Sanchita Sharma... Read more »
Important
Dr k k Aggarwal

World Covid Meter 25th June: 213 Countries Affected

Dr KK Aggarwal, President CMAAO, HCFI and Past National President IMA
26th June 2020
Multispeciality
Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22. Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity. Doubling time India 18 days, USA 33 days, Brazil 13 days, Russia 18 days, Spain 47 days, UK 35 days, Italy 55 days, France 49 days, Turkey 37 days... Read more »
Important
Dr k k Aggarwal

Association of Type 2 Diabetes and Metformin Use with Outcomes of Patients With NASH-related, Child-Pugh A Cirrhosis

26th June 2020Gastroenterology Hepatology Multispeciality
Factors that impact the outcomes of patients with non-alcoholic steatohepatitis (NASH) related cirrhosis are not clearly understood. A recent study explored the link of type 2 diabetes, levels of hemoglobin A1c (HbA1c), and use of antidiabetic... Read more »

Derma Update

Dr k k Aggarwal

A new therapeutic target in psoriasis patients is epicardial fat

26th June 2020 Dermatology
Psoriasis is a chronic inflammatory disease affecting many people around the globe. Patients with psoriasis could be at an increased risk of developing atherosclerosis that can lead to coronary artery disease and myocardial infarctions... Read more »
Important

News From All Specialities

COVID-19: WHO warns of oxygen shortage

26th June 2020 Business and Medicine Pulmonary Medicine
The world is soon going to reach 10 million coronavirus cases, the World Health Organization (WHO) chief executive said on Wednesday. As research continues into therapeutics and vaccines, efforts are needed to curb transmission and save lives... Read more »
Important
Practice Updates

India records over 17,000 new cases on Wednesday, day’s toll above 400

26th June 2020 Emergency Medicine Pathology & Lab Medicine
NEW DELHI: One of the biggest single-day hike in Covid-19 infections was noted on Wednesday in India as the country recorded over 17,000 new cases, the highest thus far. Wednesday’s death toll remained above 400 for the second day, standing at 422. Cases surged in Maharashtra with 3,890 new infections, Delhi (3,788),... Read more »
Practice Updates

FDA Approves Metoclopramide Nasal Spray for Diabetic Gastroparesis

26th June 2020 Pathology & Lab Medicine Internal Medicine
The Food and Drug Administration has granted approval to a new formulation of metoclopramide for relief of symptoms of diabetic gastroparesis in adults. The product, called Gimoti (Evoke Pharma), delivers metoclopramide via nasal administration and...Read more »

Pulse vs. Continuous Therapy for Dermatophyte Toenail Onychomycosis

26th June 2020 Pathology & Lab Medicine Dermatology
There seem to be no differences in efficacy or safety between pulse and continuous regimens of terbinafine as well as between pulse and continuous regimens of itraconazole for dermatophyte toenail onychomycosis, suggests a systematic review and network meta-analysis...Read more »
Practice Updates

Colchicine Seems Promising in COVID-19 Patients, With Caveats

26th June 2020 Pathology & Lab Medicine Pharmacists
Hospitalized patients with COVID-19 given colchicine, an anti-inflammatory drug, had improved time to clinical deterioration compared to standard of care, reports a randomized open-label trial from Greece. Clinical deterioration, defined as a decline of 2 points on a 7-grade clinical...Read more »

Hypertension Update

Dr k k Aggarwal

CCB + RAAS blocker rather than RAAS + HCTZ may be the combination of choice for high CV risk hypertensive patients

26th June 2020 Hypertension
Guidelines recommend combination therapy with complementary mechanism of actions in hypertension. The European guidelines further recommend a single pill combination to improve adherence. While calcium channel blockers (CCBs)... Read more »

Medicolegal Corner

Can an institution run by a physician be advertised? Should you advertise your medical practice?

26th June 2020
As per the provisions of Clause 6.1.1 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, soliciting of patients directly or indirectly by the physician or group of physicians or by institution or organization is unethical...Read more »

eMedi Humor

Who Would Know?

26th June 2020
The man passed out in a dead faint as he came out of his front door onto the porch. Someone called 911.
When the paramedics arrived, they helped him regain consciousness and asked if he knew what caused him to faint...Read more »

eMedi Quiz

Beta-oxidation of odd-chain fatty acids produces:

26th June 2020
1.Succinyl CoA.
2. Propionyl CoA.
3. Acetyl CoA...Read more »

Lifestyle Updates

eWellness: A mix of exercise protocol is better

26th June 2020
A combination of weight training and aerobic exercise seems to be the ideal prescription for overweight patients at risk for diabetes and heart disease. Only aerobic exercise is also as good as it reduces weight and takes inches off the waist. Just weight lifting alone has very little benefit.... Read more »
Spiritual

eSpiritual: Best time to sign a deal is at 4 pm

26th June 2020
As per Ayurveda, 2-6 pm in the evening and 2-6 am in the morning are the periods of Vata or creativity. Most poets and writers do their creative work during these times of the day, especially 2-6 am in the morning. Vata period is more creative and you are less likely to make mistakes...Read more »

Inspirational: Gossip

26th June 2020
A peasant with a troubled conscience went to a monk for advice. He said he had circulated a vile story about a friend, only to find that the story was not true. "If you would make peace with your conscience," said the monk, "you must first fill a bag with goose downs, go to every door in the village, and drop in each one of them a feather."..Read more »

Medical Voice

Karnataka: Asymptomatic patients to be discharged without further tests

26th June 2020
BENGALURU: Asymptomatic Covid-19 patients and those with mild to moderate symptoms will be now discharged at the end of their treatment cycles without further tests to confirm whether they have beaten the virus. The state government announced revised guidelines for hospital discharge on Tuesday. Until now, confirmatory tests,...Read more »

Survey

Medical voice

Doctors Survey

Question 1 : Which of these courses would you pay for - You can select multiple options
How to modernize clinic
Growing your digitize you clinic and practice...Read more » 
Medical voice

How Corona Aware Are You

Question 1 : How confident are you that you could recognize and respond to a potential coronavirus case?
Very confident
Moderately confident...Read more » 

Medbytes

From Other Newsletter

Orthopedic

Orthopedics

Special nutrition intervention needed for muscle protective efficacy of physical exercise in elderly people at risk of sarcopenia

Aging is associated with progressive loss of muscle mass and strength. In the absence of any specific interventions, it usually deteriorates into sarcopenia. A study was conducted to assess the hypothesis that combined special... Read more »

Nephrology

Orthopedics

Blood pressure control with cilnidipine treatment in Japanese post-stroke hypertensive patients

Calcium channel blockers (CCBs) are the choice of therapy for post-stroke patients. A large-scale prospective study of 2667 post-stroke hypertensive patients treated with cilnidipine assessed BP control and adverse reactions in the patients... Read more »

Pediatrics

European Commission Approves Dupilumab for Severe Asthma

The European Commission (EC) has approved dupilumab (Dupixent) as add-on maintenance therapy for patients 12 years or older with severe asthma with type 2 inflammation characterized by increased blood eosinophil levels and/or increased fractional exhaled nitric oxide,... Read more »
 

Add drkk@emedinews.org to your address book to ensure that our mails reach your Inbox.

Daily eMedinewS | Contact Us |